Well stated, totally agree. In the OTC, always expect smoke and mirrors until reliable validation is presented. IMO, the Owler business profile could have easily been manipulated to reflect 13.5 million in annual revenue. It's my recommendation not to chug the kool-aid until the SEC signs off on it with an 8K. If they got the goods, then this may be the one ticker to buy bigly into, yet not before. $APHD